Articles

Three-year results from phase 1 of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

Children’s Hospital Los Angeles, USC Norris Comprehensive Cancer Center and Keck School of Medicine, University of Southern California, Los Angeles, CA
CHOC Children’s Hospital, Orange, CA
Columbia University Irving Medical Center, New York City, NY
Texas Children’s Hospital, Houston, TX
Johns Hopkins Kimmel Cancer Center, Baltimore, MD
The Hospital for Sick Children, University of Toronto, Ontario
Vanderbilt University Medical Center, Nashville, TN
University of Miami Miller School of Medicine, Miami, FL
University of California San Francisco Benioff Children’s Hospital, San Francisco, CA
Children’s Minnesota, Minneapolis, MN
Hôpital Universitaire Robert Debré (APHP) and Université de Paris, Paris
Kite, a Gilead Company, Santa Monica, CA
Kite, a Gilead Company, Santa Monica, CA
Kite, a Gilead Company, Santa Monica, CA
Kite, a Gilead Company, Santa Monica, CA
Kite, a Gilead Company, Santa Monica, CA
Kite, a Gilead Company, Santa Monica, CA
Kite, a Gilead Company, Santa Monica, CA
University of Virginia Children's Hospital, UVA Cancer Center, UVA School of Medicine, Charlottesville, VA
Haematologica Early view Oct 20, 2022 https://doi.org/10.3324/haematol.2022.280678